These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 17669606)

  • 21. Coenzyme Q
    Wang HM; Yang HL; Thiyagarajan V; Huang TH; Huang PJ; Chen SC; Liu JY; Hsu LS; Chang HW; Hseu YC
    Integr Cancer Ther; 2017 Sep; 16(3):385-396. PubMed ID: 27821721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
    Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
    Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin.
    Domínguez-Gómez G; Díaz-Chávez J; Chávez-Blanco A; Gonzalez-Fierro A; Jiménez-Salazar JE; Damián-Matsumura P; Gómez-Quiroz LE; Dueñas-González A
    Oncol Rep; 2015 Feb; 33(2):721-8. PubMed ID: 25504347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells.
    Wang H; Lu C; Li Q; Xie J; Chen T; Tan Y; Wu C; Jiang J
    Mol Cells; 2014 Nov; 37(11):812-8. PubMed ID: 25377255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells.
    D'Onofrio G; Tramontano F; Dorio AS; Muzi A; Maselli V; Fulgione D; Graziani G; Malanga M; Quesada P
    Biochem Pharmacol; 2011 Jan; 81(2):194-202. PubMed ID: 20875401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of intracellular NAD(P)H can monitor an imbalance of DNA single strand break repair in base excision repair deficient cells in real time.
    Nakamura J; Asakura S; Hester SD; de Murcia G; Caldecott KW; Swenberg JA
    Nucleic Acids Res; 2003 Sep; 31(17):e104. PubMed ID: 12930978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells.
    Chuang HC; Kapuriya N; Kulp SK; Chen CS; Shapiro CL
    Breast Cancer Res Treat; 2012 Jul; 134(2):649-59. PubMed ID: 22678161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,3,7,8-TCDD neurotoxicity in neuroblastoma cells is caused by increased oxidative stress, intracellular calcium levels, and tau phosphorylation.
    Sul D; Kim HS; Cho EK; Lee M; Kim HS; Jung WW; Hwang KW; Park SY
    Toxicology; 2009 Jan; 255(1-2):65-71. PubMed ID: 18996433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
    Son DS; Rozman KK
    Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
    Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
    Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress initiates DNA damager MNNG-induced poly(ADP-ribose)polymerase-1-dependent parthanatos cell death.
    Chiu LY; Ho FM; Shiah SG; Chang Y; Lin WW
    Biochem Pharmacol; 2011 Feb; 81(3):459-70. PubMed ID: 21056551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Chopra M; Dharmarajan AM; Meiss G; Schrenk D
    Toxicol Sci; 2009 Sep; 111(1):49-63. PubMed ID: 19520675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester displays novel cytotoxicity through reactive oxygen species-mediated oxidative damage in MCF-7 and MDA-MB-231 cells.
    Zhang Y; Guo J; Zeng L; Zhang J; Hui Y; Liu J; Qing X; Sun X; Guo G
    Chem Biol Interact; 2011 Jul; 192(3):287-97. PubMed ID: 21536016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death.
    Zhang F; Xie R; Munoz FM; Lau SS; Monks TJ
    Toxicol Sci; 2014 Jul; 140(1):118-34. PubMed ID: 24752504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity.
    Qin XJ; Hudson LG; Liu W; Timmins GS; Liu KJ
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):41-50. PubMed ID: 18619636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells.
    Biegel L; Safe S
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):725-32. PubMed ID: 2278856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
    Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
    Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.